Saturday, November 10, 2012

2nd Drug Approved to Treat Cushing's

FDA advisory committee approves Signifor to treat Cushing's disease

  • November 7, 2012
"The FDA Endocrinologic and Metabolic Drugs Advisory Committee has voted unanimously to approve pasireotide injection for the treatment of Cushing's disease. This is the second drug labeled specifically to treat hypercortisolemia."